Sloan-Kettering Joins Sigma-Aldrich's RNAi Partnership Program | GenomeWeb
NEW YORK (GenomeWeb News) – Memorial Sloan-Kettering Cancer Center has joined Sigma-Aldrich’s RNAi Partnership Program, the St. Louis, Mo.-based firm said today.
 
Sigma-Aldrich said that members of the program gain access to products in its functional genomics portfolio including shRNA libraries developed by the RNAi Consortium that target more than 15,000 human genes and 15,000 mouse genes. Sigma-Aldrich is a member of the RNAi Consortium.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.